Cells were incubated for 15 min in HEPES-buffered saline answer containing HSP90 plus 5 mBSA-Alexa Fluor 568 (room temperature)

Cells were incubated for 15 min in HEPES-buffered saline answer containing HSP90 plus 5 mBSA-Alexa Fluor 568 (room temperature). both the protein kinase C inhibitor, rottlerin, and the c-Src inhibitor, PP2. Altogether, our results suggest that extracellular HSP90 transactivates EGFR/ErbB1 through TLR4 and a PKC/c-Src pathway, which induces ATP release and cytosolic Ca2+increase and finally favors cell migration. This mechanism could account for the deleterious effects of HSPs on high grade glioma when released into the tumor cell microenvironment. Keywords:ATP, Cell Migration, Cell Surface Receptor, Heat Shock Protein, Toll-like Receptors (TLR), Tyrosine Protein Kinase (Tyrosine Kinase) == Introduction == Glioma ranges from slowly growing low grade tumors to rapidly growing high grade tumors, including anaplastic astrocytoma and glioblastoma (1,2). High grade gliomas include anaplastic tumor cells, necrotic foci, and rich vascularity, due largely to the aberrant expression of angiogenic factors by tumor cells (3). Tumor cells are highly proliferative and invasive within the brain. Despite the development of various treatments, the life expectancy of patients remains poor (4). One of the molecules that could contribute to invasion is the stress or heat shock protein 90 (HSP90). In several tumor types, cell SBI-553 surface expression of HSP90 correlates with metastatic potential (5), and its inhibition with antibodies (6,7) or with cell-impermeable inhibitors (8) reduces cell migrationin vitro. SBI-553 Of the two HSP90 isoforms, only HSP90 has been described extracellularly, which argues against cell lysis as the source of extracellular HSP90 (8). The metalloprotease MMP-2 can be associated with extracellular HSP90 (8), which is usually favored by acetylation of the stress protein (9). Surface HSP90 also participates in extracellular matrix protein-induced c-Src/integrin association and reorganization of the actin cytoskeleton (10). The cell-impermeable inhibitor of HSP90, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG)-N-oxide, displays anti-invasive and anti-metastatic activityin vitroandin vivo, respectively, probably through the inhibition of actin polymerization and focal adhesion formation (11). Actin polymerization can be activated by tyrosine kinase receptors of the EGFR2family (12). Cell surface HSP90 interacts specifically with the extracellular domain name of HER-2 (also known as ErbB2), a ligand-less receptor, forming heterodimers with ligand-bound members ErbB1 (EGFR), ErbB3, and ErbB4. The HSP90/HER-2 conversation favors HER-2 heterodimerization with ErbB3 and signal transduction pathways via MAPK and PI3K-Akt, leading to actin rearrangement and cell motility (7). EGFR (ErbB1, or HER1) is usually overexpressed in 60% of multiform glioblastomas (13,14) and promotes invasion, proliferation, and metastasis (1517) in response to several ligands known as EGF-related peptide growth factors (18). Binding of these ligands to the extracellular domain name of EGFR leads to the formation of homo- and heterodimers, which SBI-553 triggers autophosphorylation of specific tyrosine residues within DUSP8 the cytoplasmic domain name of EGFR, inducing signaling cascades. Ligand-independent EGFR activation, referred to as EGFR transactivation, can also be observed in response to various agents such as Toll-Like receptor (TLR) agonists and stress conditions (19,20). The aim of this study was to investigate the role of extracellular HSP90 in signaling events brought on by EGFR in the human astrocytoma cell line (U87). We show that exogenously applied HSP90 mediates a cross communication between TLR4 and EGFR and accelerates cell migration. == EXPERIMENTAL PROCEDURES == == == == == == Cell Culture == Human astrocytoma cell line (U87-MG; European Collection of Cell Cultures, Sigma-Aldrich) was produced in Dulbecco’s altered Eagle’s medium (DMEM) plus 10% fetal bovine serum (Lonza) (5% CO2; 37 C). Cells were incubated 1224 h in serum-free culture medium before use. == Materials == Rabbit polyclonal anti-HSP90 and anti-HSP70 antibodies were purchased from Affinity Bioreagents. Human recombinant HSP90 protein was from StressGen (assay designs) and from BPS Bioscience. Neutralizing anti-TLR4, mouse monoclonal anti-TLR4, and rat monoclonal.